

WuXi PharmaTech , a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today proudly announced that it has won the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology.
Read Complete Story
We have yet to detect any comments for this story. Please check back shortly.
AstraZeneca and Wuxi PharmaTech announce USD 14 mln collaboration on R&D (Interfax) via www.interfax.com
Over one day ago
This Week's IPOs Part III: Cross Match Technologies, Tully's Coffee, WuXi Pharmaceutical Co. (Seeking Alpha via Yahoo! Finance) via biz.yahoo.com
Over one day ago
Wuxi Pharma Tech to set up R&D office in Tianjin (Interfax) via www.interfax.com
Over one day ago
Email WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals ... (PR Newswire via Yahoo! Finance) to a friend. You can (optionally) use the large text area below to add additional custom comments regarding WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals ... (PR Newswire via Yahoo! Finance).
The following one-click bookmarking links are made available for your convenience.